ArticleCardiovascular diabetology2023

The use of sodium-glucose co-transporter-2 inhibitors or glucagon-like peptide-1 receptor agonists versus sulfonylureas and the risk of lower limb amputations: a nation-wide cohort study.

Nikki C C Werkman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.